Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-life Study of How to Intensify Treatment With Xolair (OMALIZUMAB) in Chronic Spontaneous Urticaria

NCT04583475 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT04583475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04583475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-life Study of How to Intensify Treatment With Xolair (OMALIZUMAB) in Chronic Spontaneous Urticaria
Lead sponsor
University Hospital, Lille
Phase
Observational
Overall status
Completed
Start date
February 25, 2021
Completion date
June 22, 2023
Enrollment
163 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spontaneous urticaria, chronic